Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

FL, UNITED STATES, January 9, 2026 / EINPresswire.com / — Lila Karlsen, sustainable packaging innovator and global business leader, is set to appear on Women In Power TV, where she will share insights ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

Collaborative project with SAP team accelerates data flow from 48 hours to 20 minutes ALPHARETTA, GA, UNITED STATES, ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI ...

Insmed’s Brinsupri blew past consensus estimates in its first full quarter on the market. Elsewhere, J&J inked pharma’s ...

CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists across the company with ...

In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

While the new findings are encouraging, "vaccines won’t do any good if people don’t get them," one expert said.